Market Optimism Abounds: Telomir Pharmaceuticals (TELO) Stock Rises Significantly
Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) witnessed a substantial surge in its market performance during Thursday’s trading session, marking a remarkable 28.93% increase, culminating in shares closing at $7.31. This notable upswing in TELO’s stock price closely followed the announcement of its esteemed involvement in a significant forthcoming event. Telomir Pharmaceuticals (TELO) revealed that Dr. Michael […]
